How France negotiates drug prices and the impact of US President Donald Trump's pressure to raise them. The Paris bar celebrating sobriety as more people embrace Dry January. And the radioactive legacy of nuclear testing in French Polynesia.
Saying he wants to lower the price of medication in the United States, President Donald Trump has been putting pressure on French President Emmanuel Macron to raise the cost of an unspecified pill in France. But it's the French public health system, not Macron, that negotiates with drug companies – keeping prices for patients in check. Sociologist Theo Bourgeron believes that Trump's demand is not about improving care, but pressuring countries to weaken price controls and boost US pharmaceutical profits. (Listen @0')
